High blood pressure service increases referrals

A clinical service and primary care outreach program focused on hormonal causes of high blood pressure – the first of its kind in Victoria – has led to earlier screening and diagnosis of primary aldosteronism.

Dr Jun Yang, High blood pressure, PA
Dr Jun Yang

Primary aldosteronism (PA), or Conn’s Syndrome, is characterised by excessive secretion of the hormone aldosterone from the adrenal glands. This overproduction leads to the retention of sodium in the body, resulting in high blood pressure which is difficult to control. PA carries a higher risk of heart arrhythmia, heart attacks and strokes than ordinary hypertension.

The Endocrine Hypertension Service at Hudson Institute and Monash Health has facilitated an increase in referrals from general practitioners for primary aldosteronism screening over three years of operation. This has resulted in the earlier diagnosis and treatment of PA. The results were published in the Internal Medicine Journal, the official journal of internal medicine in the Adult Medicine Division of The Royal Australasian College of Physicians, to ensure the findings were distributed widely to doctors around Australia.

PA is the most common secondary cause of hypertension, affecting 5-10 per cent of hypertensive patients in primary care and up to 30 per cent in tertiary centres, based on international studies.

The Endocrine Hypertension Service is the first of its kind in Victoria and one of few in Australia. Over the three years since launching, patients have become less likely to have pre-existing heart or kidney damage at the time of referral, and more likely to improve their blood pressure with fewer medications.

“Our Endocrine Hypertension Service saw a six-fold increase in patients referred for early testing, two-fold decrease in end-organ damage and consistent blood pressure reduction with targeted treatment,” said Dr Jun Yang, the study’s senior author.

“Our study shows that general practitioners are more likely to screen for primary aldosteronism when there is a streamlined diagnostic pathway, such as our Endocrine Hypertension Service, together with an education program,” Dr Yang said.

“Most patients with high blood pressure rely on their GPs for testing and treatment. Increased screening among GPs will lead to more diagnoses and therefore benefit more Victorians/Australians.”

“Our goal is to accurately diagnose every patient affected by PA,” Dr Yang said.

Dr Yang was recently awarded a NHMRC Investigator Grant Emerging Leadership (Level 1) for her research into primary aldosteronism.

/Public Release. The material in this public release comes from the originating organization and may be of a point-in-time nature, edited for clarity, style and length. View in full here.